Genome-wide association study of nocturnal blood pressure dipping in hypertensive patients
Authors:
- Jenni M. RimpeläJRJenni M. Rimpelä
- Ilkka H. PörstiIPIlkka H. Pörsti
- Antti JulaAJAntti Jula
- Terho LehtimäkiTLTerho Lehtimäki
- Teemu J. NiiranenTNTeemu J. Niiranen
- Lasse OikarinenLOLasse Oikarinen
- Kimmo PorthanKPKimmo Porthan
- Antti TikkakoskiATAntti Tikkakoski
- Juha VirolainenJVJuha Virolainen
- Kimmo K. KontulaKKKimmo K. Kontula
- Timo P. HiltunenTHTimo P. Hiltunen
Open Access
- 4 July 2018
- journal article
- research article
- Published by Springer Nature in BMC Medical Genetics
- Vol. 19 (1) , 110
Abstract
Reduced nocturnal fall (non-dipping) of blood pressure (BP) is a predictor of cardiovascular target organ damage. No genome-wide association studies (GWAS) on BP dipping have been previously reported. To study genetic variation affecting BP dipping, we conducted a GWAS in Genetics of Drug Responsiveness in Essential Hypertension (GENRES) cohort (n = 204) using the mean night-to-day BP ratio from up to four ambulatory BP recordings conducted on placebo. Associations with P < 1 × 10− 5 were further tested in two independent cohorts: Haemodynamics in Primary and Secondary Hypertension (DYNAMIC) (n = 183) and Dietary, Lifestyle and Genetic determinants of Obesity and Metabolic Syndrome (DILGOM) (n = 180). We also tested the genome-wide significant single nucleotide polymorphism (SNP) for association with left ventricular hypertrophy in GENRES. In GENRES GWAS, rs4905794 near BCL11B achieved genome-wide significance (β = − 4.8%, P = 9.6 × 10− 9 for systolic and β = − 4.3%, P = 2.2 × 10− 6 for diastolic night-to-day BP ratio). Seven additional SNPs in five loci had P values < 1 × 10− 5. The association of rs4905794 did not significantly replicate, even though in DYNAMIC the effect was in the same direction (β = − 0.8%, P = 0.4 for systolic and β = − 1.6%, P = 0.13 for diastolic night-to-day BP ratio). In GENRES, the associations remained significant even during administration of four different antihypertensive drugs. In separate analysis in GENRES, rs4905794 was associated with echocardiographic left ventricular mass (β = − 7.6 g/m2, P = 0.02). rs4905794 near BCL11B showed evidence for association with nocturnal BP dipping. It also associated with left ventricular mass in GENRES. Combined with earlier data, our results provide support to the idea that BCL11B could play a role in cardiovascular pathophysiology.Keywords
Funding Information
- Sigrid Juséliuksen Säätiö
- Sydäntutkimussäätiö
- Päivikki ja Sakari Sohlbergin Säätiö
This publication has 44 references indexed in Scilit:
- 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC)Journal Of Hypertension, 2013
- Common Genetic Variation in the 3′- BCL11B Gene Desert Is Associated With Carotid-Femoral Pulse Wave Velocity and Excess Cardiovascular Disease RiskCirculation: Cardiovascular Genetics, 2012
- METAL: fast and efficient meta-analysis of genomewide association scansBioinformatics, 2010
- Genetic influences on daytime and night-time blood pressure: similarities and differencesJournal Of Hypertension, 2009
- The ERAP2 gene is associated with preeclampsia in Australian and Norwegian populationsHuman Genetics, 2009
- A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association StudiesPLOS Genetics, 2009
- Long-Range LD Can Confound Genome Scans in Admixed PopulationsThe American Journal of Human Genetics, 2008
- PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage AnalysesThe American Journal of Human Genetics, 2007
- Circadian variation of blood pressure and the vascular response to asynchronous stressProceedings of the National Academy of Sciences, 2007
- Population Structure and EigenanalysisPLOS Genetics, 2006